Literature DB >> 19844190

Astigmatic changes in orthokeratology.

Sin Wan Cheung1, Pauline Cho, Ben Chan.   

Abstract

PURPOSE: To investigate and compare changes in refractive astigmatism and corneal toricity in orthokeratology (ortho-k) using the Thibos vector analysis.
METHODS: Consecutive records of 74 patients (aged 7 to 16 years) who were fitted with spherical ortho-k lenses at the Optometry Clinic of The Hong Kong Polytechnic University between April 2000 and November 2003 and who had been on the treatment for at least 6 months were reviewed. Manifest refractive error and topographic data were retrieved from the right eye for data analysis. Changes in refractive astigmatism and corneal toricity were evaluated using the Thibos vectors (refractive vectors, RJ 0 and RJ 45; corneal vectors, CJ 0 and CJ 45) among the astigmats (refractive astigmatism 0.75 diopters cylinder (DC) or above) and the non-astigmats (refractive astigmatism 0.50 DC or less).
RESULTS: The mean changes in refractive astigmatism, RJ 0 and RJ 45 were 0.51 +/- 0.51 diopter (D), -0.31 +/- 0.35 D, and 0.09 +/- 0.16 D, respectively, among the astigmats; and 0.01 +/- 0.36 D, 0.00 +/- 0.17 D, and 0.03 +/- 0.13 D, respectively, among the non-astigmats. RJ 0 was significantly reduced, and RJ 45 was significantly increased only in the astigmats (one sample t tests, astigmats: p < 0.01; non-astigmats: p > 0.10). Although there were significant correlations between the initial RJ 0 and RJ 45 with their changes in all subjects and in the astigmats, only 21 to 55% of the variability could be explained by the regression equations (Pearson r: all subjects -0.63 < r < -0.62; astigmats -0.74 < r < -0.46, p < 0.001). No significant changes in corneal toricity and no correlations between the changes in refractive astigmatism and changes in corneal toricity were found (p > 0.13).
CONCLUSIONS: Spherical ortho-k leads to significant changes in RJ0 and RJ45, but only 38% of the variance of the changes in all subjects could be explained by relationship between changes and the initial RJ0 or RJ45. No correlation between changes in refractive astigmatism and changes in corneal toricity was found, and ortho-k treatment did not induce astigmatism in our non-astigmatic subjects.

Entities:  

Mesh:

Year:  2009        PMID: 19844190     DOI: 10.1097/OPX.0b013e3181be06ff

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  6 in total

1.  Decrease in intraocular pressure following orthokeratology measured with a noncontact tonometer.

Authors:  Yasuhito Ishida; Ryoji Yanai; Takeshi Sagara; Teruo Nishida; Hiroshi Toshida; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2011-05-15       Impact factor: 2.447

2.  Comparison of myopia control between toric and spherical periphery design orthokeratology in myopic children with moderate-to-high corneal astigmatism.

Authors:  Yu Zhang; Yue-Guo Chen
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

3.  Peripheral Refraction With Toric Orthokeratology and Soft Toric Multifocal Contact Lenses in Myopic Astigmatic Eyes.

Authors:  Erin S Tomiyama; David A Berntsen; Kathryn Richdale
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

4.  Comparison of Toric and Spherical Orthokeratology Lenses in Patients with Astigmatism.

Authors:  Jun Jiang; Lili Lian; Feifu Wang; Ling Zhou; Xuhong Zhang; E Song
Journal:  J Ophthalmol       Date:  2019-02-20       Impact factor: 1.909

5.  Corneal Elevation, Power, and Astigmatism to Assess Toric Orthokeratology Lenses in Moderate-to-High Astigmats.

Authors:  Erin S Tomiyama; Anna-Kaye Logan; Kathryn Richdale
Journal:  Eye Contact Lens       Date:  2021-02-01       Impact factor: 3.152

6.  Refractive error, visual acuity, and corneal-curvature changes in high and low myopes with orthokeratology treatment: A Malaysian study.

Authors:  Swee Lee Liong; Norhani Mohidin; Bay Wah Tan; Bariah Mohd Ali
Journal:  Taiwan J Ophthalmol       Date:  2015-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.